Peripheral Interventions Market Report 2026

Peripheral Interventions Market Overview

• Peripheral Interventions market size has reached to $10 billion in 2025 • Expected to grow to $15.28 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Rising Demand For Minimally Invasive Procedures Fueling The Growth Of The Market Due To Reduced Surgical Trauma And Faster Recovery • Market Trend: Breakthrough Intravascular Lithotripsy (IVL) Technology Enhances Treatment Of Complex Calcified Lesions In Peripheral Artery Disease (PAD) Patients • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Peripheral Interventions Market?

Peripheral interventions refer to minimally invasive procedures used to diagnose and treat conditions affecting the peripheral blood vessels outside of the heart and brain, such as those in the legs, arms, or abdomen. They are commonly used to restore circulation in the arteries of the limbs or abdomen using image-guided techniques. The main types of products in peripheral interventions are catheters, sheaths, stents, guide wires, atherectomy devices, embolic devices, thrombectomy devices, inferior vena cava (IVC) filters, and others. Catheters are thin, flexible tubes used in medical procedures to deliver or remove fluids, administer medications, measure pressures, or guide other devices into blood vessels, organs, or body cavities for diagnostic or therapeutic purposes. The various technologies involved are drug-eluting stents, balloon-expandable stents, self-expanding stents, rotational atherectomy, and directional atherectomy. These products are primarily used in various applications, such as peripheral artery disease, venous thromboembolism, and others, and they cater to a wide range of end users, including hospitals, ambulatory surgical centers, clinics, and research institutes.

What Is The Peripheral Interventions Market Growth Forecast?

The peripheral interventions market size is expected to see strong growth in the next few years. It will grow to $15.28 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to growing preference for minimally invasive treatments, technological innovation in stents and guide wires, expansion of ambulatory surgical centers, increasing healthcare expenditure in emerging markets, rising demand for faster recovery procedures. Major trends in the forecast period include shift toward minimally invasive peripheral procedures, growing adoption of drug-eluting and covered stents, increasing use of image-guided endovascular interventions, rising demand for atherectomy and thrombectomy devices, expansion of peripheral interventions in outpatient settings.

Global Peripheral Interventions Market Segmentation

1) By Product Type: Catheters, Sheath, Stents, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, Inferior Vena Cava (IVC) Filters, Other Types 2) By Technology: Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy, Directional Atherectomy 3) By Application: Peripheral Artery Disease, Venous Thromboembolism, Other Applications 4) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Specialty Vascular Centers Subsegments: 1) By Catheters: Angiographic Catheters, Balloon Catheters, Guiding Catheters, Support Catheters 2) By Sheath: Introducer Sheaths, Guiding Sheaths 3) By Stents: Bare Metal Stents, Drug-Eluting Stents, Covered Stents, Self-Expanding Stents, Balloon-Expandable Stents 4) By Guide Wires: Hydrophilic Guide Wires, Nitinol Guide Wires, Stainless Steel Guide Wires 5) By Atherectomy Devices: Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices 6) By Embolic Devices: Embolization Coils, Embolic Protection Devices, Liquid Embolic Agents 7) By Thrombectomy Devices: Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Rheolytic Thrombectomy Devices 8) By Inferior Vena Cava (IVC) Filters: Permanent Filters, Retrievable Filters 9) By Other Types: Vascular Closure Devices, Hemostatic Agents, Guide Catheter

What Is The Driver Of The Peripheral Interventions Market?

The rising demand for minimally invasive procedures is expected to propel the growth of the peripheral interventions market going forward. Minimally invasive procedures refer to medical techniques that involve performing surgeries or interventions through small incisions or natural body openings, resulting in less trauma, reduced pain, and faster recovery compared to traditional open surgery. The increase in minimally invasive procedures is driven by advancements in medical imaging and surgical technologies that enhance precision and safety during operations. Peripheral interventions help minimally invasive procedures by enabling targeted treatment of vascular conditions through small incisions, reducing the need for open surgery. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional organization, the total number of minimally invasive procedures performed in 2023 reached approximately 25.4 million, reflecting a 7% increase compared to 2022. Therefore, rising demand for minimally invasive procedures is driving the growth of the peripheral interventions industry.

Key Players In The Global Peripheral Interventions Market

Major companies operating in the peripheral interventions market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, Nipro Corporation, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., Cordis Corporation, MicroPort Scientific Corporation, Penumbra Inc., W. L. Gore & Associates Inc., Reflow Medical Inc., ArtVentive Medical Group Inc., AngioDynamics Inc., Cook Medical Inc., BD Bard Peripheral Vascular Inc., Endologix Inc., Cardiovascular Systems Inc., Surmodics Inc.

Global Peripheral Interventions Market Trends and Insights

Major companies operating in the peripheral interventions market are focusing on developing innovative solutions, such as peripheral intravascular lithotripsy catheters, to enhance the safety and efficacy of treating calcified peripheral artery disease. Peripheral intravascular lithotripsy catheters are devices that use sonic pressure waves to break up calcified plaque in peripheral arteries, making it easier and safer to perform angioplasty or place stents. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, launched the Shockwave Javelin Peripheral IVL Catheter, a novel forward IVL platform designed to treat patients with peripheral artery disease (PAD) who have difficult-to-cross, heavily calcified lesions. This innovative catheter features a 150 cm working length and a single distal emitter that delivers up to 120 shockwave pulses, creating a spherical energy field that modifies calcium and enables the device to cross extremely narrowed or occluded vessels where other devices may fail. Clinical trials demonstrated that Javelin has a safety and effectiveness profile comparable to existing balloon-based IVL catheters, offering a transformative approach to treating complex calcified peripheral lesions and improving procedural success for PAD patients.

What Are Latest Mergers And Acquisitions In The Peripheral Interventions Market?

In July 2025, Teleflex Incorporated, a US-based medical technology company, acquired the vascular intervention business of Biotronik SE & Co. KG for $892 million. Through this acquisition, Teleflex aims to expand its global presence in the peripheral intervention market, enhance its interventional cardiology portfolio, and leverage BIOTRONIK’s Vascular Intervention business to strengthen its product offerings and R&D capabilities for long-term growth and better patient outcomes. Biotronik SE & Co. KG is a Germany-based company that provides products and solutions for both coronary and peripheral vascular interventions.

Regional Outlook

North America was the largest region in the peripheral interventions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Peripheral Interventions Market?

The peripheral interventions market consists of revenues earned by entities providing services such as angioplasty and stenting procedures, atherectomy services, thrombectomy procedures, vascular imaging and diagnostics, and post-procedural patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.